{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:11:05Z","timestamp":1794035465183,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1742-4690-11-15","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T04:02:04Z","timestamp":1391659324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2"],"prefix":"10.1186","volume":"11","author":[{"given":"Tram NQ","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabelo","family":"Lukhele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Routy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric A","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"issue":"9","key":"3879_CR1","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1128\/jvi.70.9.6044-6053.1996","volume":"70","author":"BK Chen","year":"1996","unstructured":"Chen BK, Gandhi RT, Baltimore D: CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J Virol. 1996, 70 (9): 6044-6053.","journal-title":"J Virol"},{"issue":"2","key":"3879_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/156652407780059177","volume":"7","author":"OW Lindwasser","year":"2007","unstructured":"Lindwasser OW, Chaudhuri R, Bonifacino JS: Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr Mol Med. 2007, 7 (2): 171-184. 10.2174\/156652407780059177.","journal-title":"Curr Mol Med"},{"issue":"3","key":"3879_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0092-8674(88)90168-7","volume":"53","author":"M Stevenson","year":"1988","unstructured":"Stevenson M, Meier C, Mann AM, Chapman N, Wasiak A: Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell. 1988, 53 (3): 483-496. 10.1016\/0092-8674(88)90168-7.","journal-title":"Cell"},{"issue":"4780","key":"3879_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.3095925","volume":"234","author":"JA Hoxie","year":"1986","unstructured":"Hoxie JA, Alpers JD, Rackowski JL, Huebner K, Haggarty BS, Cedarbaum AJ, Reed JC: Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science. 1986, 234 (4780): 1123-1127. 10.1126\/science.3095925.","journal-title":"Science"},{"issue":"11","key":"3879_CR5","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/jvi.64.11.5585-5593.1990","volume":"64","author":"B Crise","year":"1990","unstructured":"Crise B, Buonocore L, Rose JK: CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol. 1990, 64 (11): 5585-5593.","journal-title":"J Virol"},{"key":"3879_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1742-4690-4-75","volume":"4","author":"J Binette","year":"2007","unstructured":"Binette J, Dube M, Mercier J, Halawani D, Latterich M, Cohen EA: Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology. 2007, 4: 75-10.1186\/1742-4690-4-75.","journal-title":"Retrovirology"},{"issue":"4","key":"3879_CR7","doi-asserted-by":"publisher","first-page":"e1000869","DOI":"10.1371\/journal.ppat.1000869","volume":"6","author":"JG Magadan","year":"2010","unstructured":"Magadan JG, Perez-Victoria FJ, Sougrat R, Ye Y, Strebel K, Bonifacino JS: Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 2010, 6 (4): e1000869-10.1371\/journal.ppat.1000869.","journal-title":"PLoS Pathog"},{"issue":"5","key":"3879_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/0092-8674(94)90360-3","volume":"76","author":"C Aiken","year":"1994","unstructured":"Aiken C, Konner J, Landau NR, Lenburg ME, Trono D: Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 1994, 76 (5): 853-864. 10.1016\/0092-8674(94)90360-3.","journal-title":"Cell"},{"issue":"8","key":"3879_CR9","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/jvi.68.8.5156-5163.1994","volume":"68","author":"SS Rhee","year":"1994","unstructured":"Rhee SS, Marsh JW: Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J Virol. 1994, 68 (8): 5156-5163.","journal-title":"J Virol"},{"issue":"8","key":"3879_CR10","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cub.2005.02.058","volume":"15","author":"N Michel","year":"2005","unstructured":"Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT: The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol: CB. 2005, 15 (8): 714-723. 10.1016\/j.cub.2005.02.058.","journal-title":"Curr Biol: CB"},{"issue":"7177","key":"3879_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","volume":"451","author":"SJ Neil","year":"2008","unstructured":"Neil SJ, Zang T, Bieniasz PD: Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008, 451 (7177): 425-430. 10.1038\/nature06553.","journal-title":"Nature"},{"issue":"4","key":"3879_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","volume":"3","author":"N van Damme","year":"2008","unstructured":"van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J: The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe. 2008, 3 (4): 245-252. 10.1016\/j.chom.2008.03.001.","journal-title":"Cell Host Microbe"},{"issue":"9","key":"3879_CR13","doi-asserted-by":"publisher","first-page":"e74858","DOI":"10.1371\/journal.pone.0074858","volume":"8","author":"A Smalls-Mantey","year":"2013","unstructured":"Smalls-Mantey A, Connors M, Sattentau QJ: Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils. PLoS One. 2013, 8 (9): e74858-10.1371\/journal.pone.0074858.","journal-title":"PLoS One"},{"issue":"18","key":"3879_CR14","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1073\/pnas.1016048108","volume":"108","author":"AW Chung","year":"2011","unstructured":"Chung AW, Isitman G, Navis M, Kramski M, Center RJ, Kent SJ, Stratov I: Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure. Proc Natl Acad Sci U S A. 2011, 108 (18): 7505-7510. 10.1073\/pnas.1016048108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"3879_CR15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1089\/08892220260387940","volume":"18","author":"ND Banks","year":"2002","unstructured":"Banks ND, Kinsey N, Clements J, Hildreth JE: Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS. AIDS Res Hum Retroviruses. 2002, 18 (16): 1197-1205. 10.1089\/08892220260387940.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"3879_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","volume":"23","author":"O Lambotte","year":"2009","unstructured":"Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ, Hicks CB, Owzar K, Tomaras GD, Montefiori DC, et al: Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS. 2009, 23 (8): 897-906. 10.1097\/QAD.0b013e328329f97d.","journal-title":"AIDS"},{"issue":"8","key":"3879_CR17","doi-asserted-by":"publisher","first-page":"e1002890","DOI":"10.1371\/journal.ppat.1002890","volume":"8","author":"MD Alpert","year":"2012","unstructured":"Alpert MD, Harvey JD, Lauer WA, Reeves RK, Piatak M, Carville A, Mansfield KG, Lifson JD, Li W, Desrosiers RC, et al: ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. PLoS Pathog. 2012, 8 (8): e1002890-10.1371\/journal.ppat.1002890.","journal-title":"PLoS Pathog"},{"issue":"14","key":"3879_CR18","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1128\/JVI.00171-11","volume":"85","author":"G Ferrari","year":"2011","unstructured":"Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S, Moody MA, Alam SM, Tomaras GD, Ochsenbauer C, et al: An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum. J Virol. 2011, 85 (14): 7029-7036. 10.1128\/JVI.00171-11.","journal-title":"J Virol"},{"issue":"21","key":"3879_CR19","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1128\/JVI.01023-12","volume":"86","author":"M Bonsignori","year":"2012","unstructured":"Bonsignori M, Pollara J, Moody MA, Alpert MD, Chen X, Hwang KK, Gilbert PB, Huang Y, Gurley TC, Kozink DM, et al: Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. J Virol. 2012, 86 (21): 11521-11532. 10.1128\/JVI.01023-12.","journal-title":"J Virol"},{"issue":"22","key":"3879_CR20","doi-asserted-by":"publisher","first-page":"9019","DOI":"10.1073\/pnas.1301456110","volume":"110","author":"GD Tomaras","year":"2013","unstructured":"Tomaras GD, Ferrari G, Shen X, Alam SM, Liao HX, Pollara J, Bonsignori M, Moody MA, Fong Y, Chen X, et al: Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proc Natl Acad Sci U S A. 2013, 110 (22): 9019-9024. 10.1073\/pnas.1301456110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"3879_CR21","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, et al: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009, 361 (23): 2209-2220. 10.1056\/NEJMoa0908492.","journal-title":"N Engl J Med"},{"issue":"7158","key":"3879_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, et al: Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 2007, 449 (7158): 101-104. 10.1038\/nature06106.","journal-title":"Nature"},{"issue":"8","key":"3879_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/nm.1974","volume":"15","author":"AJ Hessell","year":"2009","unstructured":"Hessell AJ, Poignard P, Hunter M, Hangartner L, Tehrani DM, Bleeker WK, Parren PW, Marx PA, Burton DR: Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med. 2009, 15 (8): 951-954. 10.1038\/nm.1974.","journal-title":"Nat Med"},{"issue":"1","key":"3879_CR24","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1073\/pnas.1217609110","volume":"110","author":"Y Guan","year":"2013","unstructured":"Guan Y, Pazgier M, Sajadi MM, Kamin-Lewis R, Al-Darmarki S, Flinko R, Lovo E, Wu X, Robinson JE, Seaman MS, et al: Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding. Proc Natl Acad Sci USA. 2013, 110 (1): E69-E78. 10.1073\/pnas.1217609110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3879_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1101\/cshperspect.a006866","volume":"2","author":"CB Wilen","year":"2012","unstructured":"Wilen CB, Tilton JC, Doms RW: HIV: cell binding and entry. Cold Spring Harb Perspect Med. 2012, 2: 8-","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3879_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-4614-0980-9_10","volume":"726","author":"CB Wilen","year":"2012","unstructured":"Wilen CB, Tilton JC, Doms RW: Molecular mechanisms of HIV entry. Adv Exp Med Biol. 2012, 726: 223-242. 10.1007\/978-1-4614-0980-9_10.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"3879_CR27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/jvi.70.2.1100-1108.1996","volume":"70","author":"A Trkola","year":"1996","unstructured":"Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H: Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol. 1996, 70 (2): 1100-1108.","journal-title":"J Virol"},{"issue":"12","key":"3879_CR28","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/jvi.64.12.5701-5707.1990","volume":"64","author":"U Olshevsky","year":"1990","unstructured":"Olshevsky U, Helseth E, Furman C, Li J, Haseltine W, Sodroski J: Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol. 1990, 64 (12): 5701-5707.","journal-title":"J Virol"},{"issue":"5","key":"3879_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.chom.2010.10.008","volume":"8","author":"AH Shah","year":"2010","unstructured":"Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker E: Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe. 2010, 8 (5): 397-409. 10.1016\/j.chom.2010.10.008.","journal-title":"Cell Host Microbe"},{"key":"3879_CR30","volume-title":"J Virol","author":"M Veillette","year":"2013","unstructured":"Veillette M, Desormeaux A, Medjahed H, Gharsallah NE, Coutu M, Baalwa J, Guan Y, Lewis G, Ferrari G, Hahn BH, et al: Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity. J Virol. 2013, epub available Dec 18"},{"issue":"5","key":"3879_CR31","doi-asserted-by":"publisher","first-page":"e1000429","DOI":"10.1371\/journal.ppat.1000429","volume":"5","author":"B Jia","year":"2009","unstructured":"Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT: Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin\/BST2. PLoS Pathog. 2009, 5 (5): e1000429-10.1371\/journal.ppat.1000429.","journal-title":"PLoS Pathog"},{"issue":"1","key":"3879_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.chom.2009.05.008","volume":"6","author":"F Zhang","year":"2009","unstructured":"Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, Johnson MC, Munch J, Kirchhoff F, Bieniasz PD, Hatziioannou T: Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe. 2009, 6 (1): 54-67. 10.1016\/j.chom.2009.05.008.","journal-title":"Cell Host Microbe"},{"key":"3879_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0021-9673(01)87461-6","volume":"326","author":"HW Lahm","year":"1985","unstructured":"Lahm HW, Stein S: Characterization of recombinant human interleukin-2 with micromethods. J Chromatogr. 1985, 326: 357-361.","journal-title":"J Chromatogr"},{"issue":"9","key":"3879_CR34","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1128\/jvi.69.9.5723-5733.1995","volume":"69","author":"R Wyatt","year":"1995","unstructured":"Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J: Involvement of the V1\/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol. 1995, 69 (9): 5723-5733.","journal-title":"J Virol"},{"issue":"4","key":"3879_CR35","doi-asserted-by":"publisher","first-page":"e1000856","DOI":"10.1371\/journal.ppat.1000856","volume":"6","author":"M Dube","year":"2010","unstructured":"Dube M, Roy BB, Guiot-Guillain P, Binette J, Mercier J, Chiasson A, Cohen EA: Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 2010, 6 (4): e1000856-10.1371\/journal.ppat.1000856.","journal-title":"PLoS Pathog"},{"issue":"1","key":"3879_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1742-4690-10-128","volume":"10","author":"VP Dave","year":"2013","unstructured":"Dave VP, Hajjar F, Dieng MM, Haddad E, Cohen EA: Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice. Retrovirology. 2013, 10 (1): 128-10.1186\/1742-4690-10-128.","journal-title":"Retrovirology"},{"issue":"7","key":"3879_CR37","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1371\/journal.ppat.0030085","volume":"3","author":"JP Belzile","year":"2007","unstructured":"Belzile JP, Duisit G, Rougeau N, Mercier J, Finzi A, Cohen EA: HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog. 2007, 3 (7): e85-10.1371\/journal.ppat.0030085.","journal-title":"PLoS Pathog"},{"issue":"30","key":"3879_CR38","doi-asserted-by":"publisher","first-page":"28346","DOI":"10.1074\/jbc.M300327200","volume":"278","author":"K Levesque","year":"2003","unstructured":"Levesque K, Zhao YS, Cohen EA: Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J Biol Chem. 2003, 278 (30): 28346-28353. 10.1074\/jbc.M300327200.","journal-title":"J Biol Chem"},{"issue":"7","key":"3879_CR39","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1182\/blood-2009-08-237370","volume":"115","author":"J Richard","year":"2010","unstructured":"Richard J, Sindhu S, Pham TN, Belzile JP, Cohen EA: HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood. 2010, 115 (7): 1354-1363. 10.1182\/blood-2009-08-237370.","journal-title":"Blood"},{"issue":"4","key":"3879_CR40","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/S0021-9258(18)53861-8","volume":"268","author":"JP Northrop","year":"1993","unstructured":"Northrop JP, Ullman KS, Crabtree GR: Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem. 1993, 268 (4): 2917-2923.","journal-title":"J Biol Chem"},{"issue":"33","key":"3879_CR41","doi-asserted-by":"publisher","first-page":"13688","DOI":"10.1073\/pnas.1101684108","volume":"108","author":"E Erikson","year":"2011","unstructured":"Erikson E, Adam T, Schmidt S, Lehmann-Koch J, Over B, Goffinet C, Harter C, Bekeredjian-Ding I, Sertel S, Lasitschka F, et al: In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317\/BST-2\/HM1.24\/tetherin in humans. Proc Natl Acad Sci USA. 2011, 108 (33): 13688-13693. 10.1073\/pnas.1101684108.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-11-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:03:38Z","timestamp":1630551818000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-11-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,6]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3879"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-11-15","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,6]]},"assertion":[{"value":"15 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}